Wenzel Spine, based in Austin, Texas, has announced the 26,000th successful implantation of the Stand-Alone VariLift Expandable Interbody Fusion Device, according to a company news release.
The device is the only product cleared by the Food and Drug Administration as a stand-alone interbody fusion device that expands in-situ for minimally invasive procedures. The device can be used for single or two contiguous levels in the lumbar spine during transforaminal and anterior lumbar interbody fusion.
The system includes the VariLift-C, a device designed for cervical spine surgery applications, which has the CE Mark approval in Europe.
Related Articles on Wenzel Spine:
Wenzel Spine Hires Jon Luedke as Executive Vice President
Wenzel Spine Launches Multimedia Profiles
Wenzel Spine Receives FDA Clearance on Spinal System
The device is the only product cleared by the Food and Drug Administration as a stand-alone interbody fusion device that expands in-situ for minimally invasive procedures. The device can be used for single or two contiguous levels in the lumbar spine during transforaminal and anterior lumbar interbody fusion.
The system includes the VariLift-C, a device designed for cervical spine surgery applications, which has the CE Mark approval in Europe.
Related Articles on Wenzel Spine:
Wenzel Spine Hires Jon Luedke as Executive Vice President
Wenzel Spine Launches Multimedia Profiles
Wenzel Spine Receives FDA Clearance on Spinal System